Complete your online assessment
Start with a short questionnaire about your health history and your goals. You can complete it from any device in Nebraska, at whatever hour suits you, with no office to travel to.
An online path to personalized compounded semaglutide for people in Nebraska. You answer a health questionnaire, a licensed provider reviews it, and if treatment is appropriate your prescription is filled by a pharmacy partner and delivered to you.
How it works
Three steps, all online, from the first question to the delivery at your door.
Start with a short questionnaire about your health history and your goals. You can complete it from any device in Nebraska, at whatever hour suits you, with no office to travel to.
A licensed provider with Wasef Health, PC, the clinical organization for applicable Bodi Envi programs, reads your answers and decides whether personalized compounded semaglutide is a safe and appropriate option for you.
When a provider prescribes, the prescription goes to VialsRx, the pharmacy partner for GLP-1 programs, which prepares it and sends it to your Nebraska address.
Please note: a licensed provider determines whether treatment is appropriate. Treatment is not guaranteed. If a patient is not qualified, a refund will be issued.
Semaglutide is a GLP-1 receptor agonist. It acts on the same receptor as GLP-1, a hormone the gut releases after a meal that plays a part in appetite and blood sugar regulation. For Nebraska residents, it is the medication behind Bodi Envi's Personalized Compounded Semaglutide Weight-Management Programs.
Personalized Compounded Semaglutide is a version of that active ingredient prepared by a licensed compounding pharmacy from a prescription written for an individual patient. It is taken as a weekly injection, and the starting dose and any later change are decided by the prescribing provider, not by the patient and not by Bodi Envi.
It is important to be clear about what compounded means. Personalized Compounded Semaglutide has not been approved by the FDA and is not the same as Ozempic® and Wegovy®, the FDA-approved products. Compounded drugs are not reviewed by the FDA for safety, effectiveness or quality before they are marketed. Brand names are trademarks of their respective owners. Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards.
There is one price list, and it applies in Nebraska exactly as it does everywhere else. Pick the term that suits you, from monthly to twelve months, knowing that a dose adjustment from your provider will not raise the price.
Billed monthly
$435 paid once
$810 paid once
$1,500 paid once
For applicable programs, pricing does not increase based solely on dosage strength. Medication is included only when a licensed healthcare provider determines treatment is medically appropriate and issues a prescription. Current pricing and plan details are on the Plans page.
Because nothing depends on a physical location, Nebraska is served as a whole. Residents of Omaha, Lincoln, Bellevue, Grand Island, Kearney and Fremont and of the towns between them complete the same online assessment and, if personalized compounded semaglutide is prescribed, receive it at a valid address anywhere in the state.
Bodi Envi is a telehealth platform, so the whole process happens where you already are. Someone in Kearney and someone in Fremont complete the same assessment from home, are reviewed by the same licensed providers, and message the care team through the same secure channel. If personalized compounded semaglutide is prescribed, it is delivered to a home address in Nebraska rather than collected from a clinic. Distance from a city stop being a factor in whether Nebraska residents can be seen.
Straight answers about eligibility, pricing and how the program works where you live.
Yes. Bodi Envi connects eligible adults in Nebraska with licensed healthcare providers who can prescribe personalized compounded semaglutide when it is clinically appropriate. If prescribed, the medication is dispensed by a licensed pharmacy partner and shipped to your Nebraska address. Compounded medications are not FDA-approved.
Published pricing is the same for Nebraska residents as for everyone else. The same four plans apply in Nebraska as everywhere else: $155 a month on monthly billing, $145 a month on the 3-month term, $135 a month on the 6-month term and $125 a month on the 12-month term. Pricing does not increase based solely on dosage strength. Current pricing is always on the /pricing page.
No. Bodi Envi is a telehealth platform. You complete an online health assessment, and a licensed provider with Wasef Health, PC reviews it and determines whether treatment is appropriate. In most states your tailored treatment plan is delivered through online questionnaire and secure chat.
A licensed healthcare provider does, after an independent evaluation of your assessment. Wasef Health, PC, led by Medical Director Michael Wasef, MD, provides clinical services for applicable Bodi Envi programs, including for Nebraska patients.
The current pharmacy partner for GLP-1 prescriptions is VialsRx. Once a licensed provider prescribes personalized compounded semaglutide, the pharmacy partner dispenses it and handles delivery. Availability may vary by program and patient location.
No, and the difference matters. Personalized Compounded Semaglutide is prepared by a compounding pharmacy for an individual patient and is not FDA-approved, while Ozempic® and Wegovy® are FDA-approved products. Compounded medications are not equivalent to them. Brand names are trademarks of their respective owners. Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards.
Yes. Bodi Envi is a LegitScript-certified telehealth platform. You can confirm the certification on LegitScript's own site through the badge in the footer of every page.
Yes. Both personalized compounded semaglutide and personalized compounded tirzepatide programs are available to eligible adults in Nebraska, along with micro-dose versions of each. A provider with Wasef Health, PC recommends the option that fits your health history and goals.
Yes. Micro-dose semaglutide is one of Bodi Envi's programs, and Nebraska patients are assessed for it the same way as for the standard program. Whether it is prescribed is the decision of a licensed provider with Wasef Health, PC.
The next step belongs to the licensed provider with Wasef Health, PC, who reads your assessment and determines whether treatment is appropriate. Treatment is not guaranteed. If a patient is not qualified, a refund will be issued. If personalized compounded semaglutide is prescribed, the pharmacy partner fills the prescription and ships it to your Nebraska address, and ongoing monitoring happens through the care team.
Personalized compounded semaglutide and personalized compounded tirzepatide are not FDA-approved and are not equivalent to FDA-approved products.
The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed.
Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards.
Treatment is not guaranteed. A licensed healthcare provider determines whether treatment is appropriate for each individual patient. Individual experiences and outcomes vary. If a patient is not qualified, a refund will be issued.
Bodi Envi is not a medical practice, pharmacy, or medication manufacturer. Brand names are trademarks of their respective owners.
Complete the online assessment in a few minutes. A licensed provider reviews it, and if personalized compounded semaglutide is right for you, your plan ships to your Nebraska address. Treatment is not guaranteed, and the price you see is the price Nebraska residents pay. If a patient is not qualified, a refund will be issued.